Teva stock jumps on Q1 earnings, successful trial results

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

Schizophrenia Treatment News

Business Business Latest News,Business Business Headlines

Teva Pharmaceutical (TEVA) stock is trading higher on Wednesday, following the company's beat in its first quarter earnings report. Contributing further to...

) stock is trading higher on Wednesday, following the company's beat in its first quarter earnings report. Contributing further to the rally, Teva unveiled encouraging results from a clinical study evaluating its Schizophrenia treatment, Olanzapine, driving shares higher.Let's talk about Teva as well.

Known as the Oracle of Omaha, Warren Buffett is one of the most successful investors of all time. He started his first investment partnership in 1956 with a few friends and family. An investment in...CALGARY — Suncor Energy Inc. says it is leasing and operating a number of Aframax oil tanker ships to carry crude from the recently completed Trans Mountain pipeline expansion to Pacific markets.

Nvidia will surge another 22%, and is still cheap compared to peers despite nearly doubling this year, Goldman Sachs says

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Report calls for changes to government’s interaction with drug-pricing board, pharmaceutical industryOther recommendations in the House of Commons report include a call for the government to spell out the mandate of the PMPRB and for Ottawa to review how it enacts drug price regulatory reforms
Source: globeandmail - 🏆 5. / 92 Read more »

Swiss pharmaceutical company Novartis to cut 680 jobs in product developmentAround 440 jobs will go in Switzerland and up to 240 in the United States over the next two to three years, the Basel-based company said
Source: globebusiness - 🏆 31. / 66 Read more »